Novelion Therapeutics Inc. appointed Michael Price as CFO and senior vice president, effective Dec. 4.
Price joins Novelion from Noven Pharmaceuticals Inc., where he served as vice president and CFO.
Gregory Perry has resigned as CFO of Novelion to pursue other opportunities, and will remain with the company until Dec. 31 to enable an effective transition.